FDA approves oral version of weight-loss drug semaglutide, UAB researchers react
December 22, 2025
December 22, 2025
BIRMINGHAM, Alabama, Dec. 22 -- The University of Alabama issued the following news:
* * *
FDA approves oral version of weight-loss drug semaglutide, UAB researchers react
*
An oral formulation of semaglutide has received United States Food and Drug Administration approval for a new drug or biologic under the Prescription Drug User Fee Act.
The University of Alabama at Birmingham served as one of the clinical trial sites, led by W . . .
* * *
FDA approves oral version of weight-loss drug semaglutide, UAB researchers react
*
An oral formulation of semaglutide has received United States Food and Drug Administration approval for a new drug or biologic under the Prescription Drug User Fee Act.
The University of Alabama at Birmingham served as one of the clinical trial sites, led by W . . .